---
title: "Webinar from VeriSIM Life | AI in Drug Development: Hype or Reality?"
description: This discussion explores how adopting AI and deep technology to the R&D process reduces costs and accelerates time to market whilst maintaining safety.
---

[![VeriSIM_Logo_FullColor_Medium (1)](https://info.verisimlife.com/hs-fs/hubfs/VeriSIM_Logo_FullColor_Medium%20(1).png?width=200&height=39&name=VeriSIM_Logo_FullColor_Medium%20(1).png "VeriSIM_Logo_FullColor_Medium (1)")](https://www.verisimlife.com)

![diagonal-hero-image](https://info.verisimlife.com/hs-fs/hubfs/diagonal-hero-image.jpg?width=457&height=319&name=diagonal-hero-image.jpg "diagonal-hero-image")

### View Now

AI in Drug Development: Hype or Reality?

 

This discussion between VeriSIM Life and experts at Pfizer, Bayer and Janssen explores how adopting AI and deep technology to the R&D process reduces costs and accelerates time to market whilst maintaining safety.

*Key themes include:*

• Identifying the most common barriers preventing the successful adoption of AI initiatives for drug development in small and large organizations

• Comparing the challenges with applying AI to determine safety and efficacy: Small molecule vs. large molecule candidates

• Understanding how general and deterministic systems approach PK/PD/E predictions differently: What are the impacts?

• AI adoption and the impacts of user interfaces (UI and UX) on different user groups

• Overcoming data capture, accessibility and analytic challenges: Ensuring availability of accurate, usable data for generation and prediction

<https://twitter.com/VeriSIMlife> <https://www.linkedin.com/company/verisim-life/> <https://twitter.com/VeriSIMlife> [mailto:info@verisimlife.com](mailto:info@verisimlife.com)

© 2021 VeriSIM Life. All rights reserved.